Challenges in tackling rheumatic heart disease in developing worl | 56671
Clinical & Experimental Cardiology

Clinical & Experimental Cardiology
Open Access

ISSN: 2155-9880

Challenges in tackling rheumatic heart disease in developing world

3rd Global Summit on Heart Diseases

November 02-03, 2017 Bangkok, Thailand

Arun Prasad

All India Institute of Medical Sciences, India

Scientific Tracks Abstracts: J Clin Exp Cardiolog

Abstract :

Statement of the Problem: Rheumatic Heart Disease (RHD) is a major cause of long term morbidity and premature mortality in developing world. It is a disease causing damage to the cardiac valves which is sequel to Acute Rheumatic Fever (ARF) developing aft er infection with group a Beta hemolytic streptococcus. Th e important fact is that this disease is preventable and controllable. It may lead to chronic morbidity with repeated hospitalization and oft en unaff ordable cardiac surgery. Rheumatic fever aff ects school aged children primarily and over 330000 children between the ages of 5 and 14 years are aff ected by rheumatic fever each year with global prevalence of 0.3-5.7/1000. Deaths from rheumatic heart disease are estimated between 250 000 and 468 000 annually. A single tertiary cardiac centre in western India registered 120 deaths in a year. Th e improvement in the living standards with better sanitation, avoidance of overcrowding and overall betterment in healthcare system will improve the above fi gures. Th e other important areas where the disease can be attacked are - community awareness regarding the disease, and Primary and secondary prophylaxis. In India there is no structured community awareness program on Rheumatic fever. Community awareness regarding relationship of sore throat and joint pain with the heart disease may lead to early healthcare seeking, which will lead to improved primary prevention and early detection of acute rheumatic fever. Registry of acute rheumatic fever and RHD cases will help in ensuring regular secondary prophylaxis. Injection Benzathine Penicillin is most commonly used medicine for secondary prophylaxis. It is very cheap but yet not available in most of the government hospitals. Conclusion & Signifi cance: Community awareness regarding RF/RHD, early case detection and ensuring regular secondary prophylaxis with registry system are some of the preventive strategies to reduce morbidity and mortality due to RHD in developing world. Recent Publications: 1. Porth C. Essentials of pathophysiology: concepts of altered health states. Hagerstown, MD: Lippincott Williams & Wilkins; 2007 2. Carapetis JR, Steer AC, Mulholland EK, Weber M. Th e global burden of group A streptococcal diseases. Lancet Infect Dis. 2005;5:685ΓΆΒ?Β?94 3. Steer A, Colquhuon S, Noonan S, Kaelo J, Viali S, Carapetis J. Control of rheumatic heart disease in the Pacifi c region. Pac Public Dialog. 2006;13:49ΓΆΒ?Β?55. 4. Marijon E, Mirabel M, Celermajer DS, Jouven XL. Rheumatic heart disease. Lancet. 2012;379:953ΓΆΒ?Β?64 5. Prasad A, Kumar S, Singh BK, Kumari N (2017) Mortality Due to Rheumatic Heart Disease in Developing World: A Preventable Problem. J Clin Exp Cardiolog. 8: 503.

Biography :

Arun Prasad is working as Assistant Professor of Pediatrics in Emergency department at All India Institute of Medical sciences, Patna. He has previously worked in Pediatric cardiology department for 5 years. He has an experience of 10 tears of doing echocardiography. He is keen to improve morbidity and mortality due to Rheumatic heart disease in the region. He has developed Rheumatic heart disease control committee in the institute he is working in. In December 2016 he highlighted the burden of Rheumatic heart disease in world cardiology congress at Dubai.